# DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris

> **NCT03633890** · PHASE4 · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 102 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** DaZhu Rhodiola Rosea Capsule
- **DRUG:** DaZhu Rhodiola Rosea Simulation Capsule

## Key facts

- **NCT ID:** NCT03633890
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633890, "DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03633890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*